Mitochondrial BCAA transporter in physiology and disease

生理学和疾病中的线粒体支链氨基酸转运蛋白

基本信息

  • 批准号:
    10532174
  • 负责人:
  • 金额:
    $ 45.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-15 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Emerging evidence suggests that brown adipose tissue (BAT) functions as a significant metabolic-sink for glucose and fatty acids, but also branched-chain amino acids (BCAA; valine, leucine, and isoleucine). Our recent study shows that cold-activated BCAA catabolism in the BAT promotes systemic BCAA clearance in mice and humans, and that this metabolic-sink action is tightly coupled with its ability to improve glucose tolerance and insulin sensitivity. The notion of BAT being a metabolic-sink for BCAA provides new insights into the epidemiological observations that increased circulating BCAA levels are associated with insulin resistance and type 2 diabetes, conditions under which BAT mass/activity is reduced. However, the mechanisms remain insufficiently understood because the gatekeeper of mitochondrial BCAA transport, i.e., mitochondrial BCAA transporter that determines BCAA fate in the mitochondria vs. cytosol, was unknown for many years. We recently identified the first mitochondrial BCAA transporter, SLC25A44, in mammals. Our preliminary data suggest that SLC25A44 is required for mitochondria BCAA oxidation, BAT thermogenesis, and systemic glucose homeostasis. Accordingly, this proposal aims to determine the mechanisms by which SLC25A44 loss causes systemic glucose intolerance and insulin resistance. First, we will determine the metabolic organ that is primarily responsible for the diabetic phenotype through characterization of the newly developed BAT-specific SLC25A44 deficient mice. Second, we will employ metabolomics and biochemical approaches to determine the molecular mechanisms by which SLC25A44 loss alters mitochondrial function and intracellular signaling pathways. Lastly, we aim to examine the regulatory mechanisms of SLC25A44 expression and function. The work resulting from this application will establish a conceptual framework to understand the regulation of intracellular BCAA fate, and also provide a new roadmap to reverse disease phenotypes that stem from dysregulation in the BCAA catabolic processes.
项目摘要 新出现的证据表明,棕色脂肪组织(BAT)作为一个重要的代谢库, 葡萄糖和脂肪酸,还有支链氨基酸(BCAA;缬氨酸、亮氨酸和异亮氨酸)。我们最近 研究表明,BAT中的冷活化BCAA催化剂促进小鼠全身BCAA清除, 人类,并且这种代谢库作用与其改善葡萄糖耐量的能力紧密相关, 胰岛素敏感性 BAT是BCAA代谢汇的概念为流行病学观察提供了新的见解 循环中支链氨基酸水平的增加与胰岛素抵抗和2型糖尿病有关, 在此情况下,BAT质量/活性降低。然而,这些机制仍然没有得到充分的理解, 线粒体BCAA转运的看门人,即,决定支链氨基酸的线粒体支链氨基酸转运蛋白 线粒体与细胞质中的命运,多年来一直是未知的。 我们最近在哺乳动物中发现了第一个线粒体BCAA转运蛋白SLC 25 A44。我们的初步数据 表明SLC 25 A44是线粒体BCAA氧化、BAT产热和全身葡萄糖所必需 体内平衡因此,本提案旨在确定SLC 25 A44缺失导致的机制。 全身性葡萄糖耐受不良和胰岛素抵抗。首先,我们将确定代谢器官, 通过表征新开发的BAT特异性SLC 25 A44负责糖尿病表型 缺陷小鼠其次,我们将采用代谢组学和生物化学方法来确定分子水平。 SLC 25 A44缺失改变线粒体功能和细胞内信号通路的机制。最后, 我们的目的是研究SLC 25 A44的表达和功能的调节机制。工作产生于 本申请将建立理解细胞内BCAA命运调节的概念框架, 并提供了一个新的路线图,以扭转疾病的表型,源于失调的支链氨基酸 分解代谢过程

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism.
  • DOI:
    10.1038/s41598-022-19245-x
  • 发表时间:
    2022-09-01
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Yoshida, Yohko;Shimizu, Ippei;Shimada, Atsuhiro;Nakahara, Keita;Yanagisawa, Sachiko;Kubo, Minoru;Fukuda, Shinji;Ishii, Chiharu;Yamamoto, Hiromitsu;Ishikawa, Takamasa;Kano, Kuniyuki;Aoki, Junken;Katsuumi, Goro;Suda, Masayoshi;Ozaki, Kazuyuki;Yoshida, Yutaka;Okuda, Shujiro;Ohta, Shigeo;Okamoto, Shiki;Minokoshi, Yasuhiko;Oda, Kanako;Sasaoka, Toshikuni;Abe, Manabu;Sakimura, Kenji;Kubota, Yoshiaki;Yoshimura, Norihiko;Kajimura, Shingo;Zuriaga, Maria;Walsh, Kenneth;Soga, Tomoyoshi;Minamino, Tohru
  • 通讯作者:
    Minamino, Tohru
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shingo Kajimura其他文献

Shingo Kajimura的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shingo Kajimura', 18)}}的其他基金

Molecular Control of Brown Adipose Cell Fate and Energy Metabolism
棕色脂肪细胞命运和能量代谢的分子控制
  • 批准号:
    10094152
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Post-translational control of adipose tissue remodeling and metabolic health
脂肪组织重塑和代谢健康的翻译后控制
  • 批准号:
    10264160
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10226352
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10643941
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10064156
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Molecular control of beige fat heterogeneity
米色脂肪异质性的分子控制
  • 批准号:
    10220026
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Mitochondrial metabolite compartmentalization in health and disease
健康和疾病中的线粒体代谢物区室化
  • 批准号:
    10435518
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Post-translational control of adipose tissue remodeling and metabolic health
脂肪组织重塑和代谢健康的翻译后控制
  • 批准号:
    10453585
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Molecular control of beige fat heterogeneity
米色脂肪异质性的分子控制
  • 批准号:
    10645161
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Molecular control of beige fat heterogeneity
米色脂肪异质性的分子控制
  • 批准号:
    10026279
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:

相似海外基金

Targeting the Amino Acid Transporter SLC7A5 for Pulmonary Fibrosis
靶向氨基酸转运蛋白 SLC7A5 治疗肺纤维化
  • 批准号:
    10630480
  • 财政年份:
    2023
  • 资助金额:
    $ 45.5万
  • 项目类别:
Determinants of amino acid transporter oligomerization in membranes
膜中氨基酸转运蛋白寡聚的决定因素
  • 批准号:
    10725968
  • 财政年份:
    2023
  • 资助金额:
    $ 45.5万
  • 项目类别:
Amino acid transporter SLC38A5 as a drug target for TNBC: Evaluation with genetic and pharmacologic approaches
氨基酸转运蛋白 SLC38A5 作为 TNBC 的药物靶点:用遗传和药理学方法进行评估
  • 批准号:
    10576760
  • 财政年份:
    2022
  • 资助金额:
    $ 45.5万
  • 项目类别:
Targeting the Amino Acid Transporter SLC7A5 for Treatment of Pulmonary Fibrosis
靶向氨基酸转运蛋白 SLC7A5 治疗肺纤维化
  • 批准号:
    10683793
  • 财政年份:
    2022
  • 资助金额:
    $ 45.5万
  • 项目类别:
Structural and functional elucidation of L-type amino acid transporter under lipid environment
脂质环境下L型氨基酸转运蛋白的结构和功能阐明
  • 批准号:
    21K15031
  • 财政年份:
    2021
  • 资助金额:
    $ 45.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of new BNCT sensitizer based on molecular chirality recognition of amino acid transporter LAT
基于氨基酸转运蛋白LAT的分子手性识别开发新型BNCT敏化剂
  • 批准号:
    21K19348
  • 财政年份:
    2021
  • 资助金额:
    $ 45.5万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Elucidation of tissue-repair response in lung fibrosis by focusing on the amino acid transporter SLC15A3
通过关注氨基酸转运蛋白 SLC15A3 阐明肺纤维化中的组织修复反应
  • 批准号:
    21K16155
  • 财政年份:
    2021
  • 资助金额:
    $ 45.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Hybridized structure- and ligand- based drug discovery approaches targeting ASCT2, an amino acid transporter critical for upregulated cell proliferation in numerous cancer types
针对 ASCT2 的基于杂交结构和配体的药物发现方法,ASCT2 是一种氨基酸转运蛋白,对于多种癌症类型的细胞增殖上调至关重要
  • 批准号:
    10333203
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
Exploration of new therapeutic strategy targeting amino acid transporter in renal cell carcinoma
肾细胞癌靶向氨基酸转运蛋白治疗新策略的探索
  • 批准号:
    20K18108
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating the Physiological Role of Cl- permeation through Excitatory Amino Acid Transporter 1 (
通过兴奋性氨基酸转运蛋白 1 研究氯渗透的生理作用(
  • 批准号:
    552252-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 45.5万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了